Mackie Research analysts Andre Uddin and Yue “Toby” Ma recently reviewed three junior healthcare stocks that they rate as ‘speculative buys’.
Appili Therapeutics Inc. (TSX—APLI)
Founded to advance the global fight against   Read More

With the slow rollout of cannabis stores in Ontario, pot stocks have been beaten down. But that has made some of them more attractively valued.

After initially getting upset at Aphria   Read More

Healthcare stock Extendicare operates over 120 long-term care and retirement home facilities across Canada and runs its home care business through 35 branches across the country.

Healthcare stock Extendicare Inc. (TSX—EXE)   Read More

With the slow rollout of cannabis stores in Ontario, pot stocks have been beaten down. But that has made some of them more attractively valued.

After initially getting upset at Aphria   Read More

Portfolio manager and financial analyst John Kim picks two US blue chip stocks as his current ‘best buys’: CVS Health Corp. and AT&T Inc.
Caution is the name of the game   Read More

Healthcare stock Abacus Health Products develops and commercializes over-the-counter topical pain relief and therapeutic skincare products.
Abacus Health Products Inc. (CNSX—ABCS) is poised to become a leader in the topical pain   Read More

While drugs and gold were the two most popular forms of payment for votes in the recent election in India, portfolio manager Elvis Picardo proffers far better reasons for picking   Read More

While drugs and gold were the two most popular forms of payment for votes in the recent election in India, portfolio manager Elvis Picardo proffers far better reasons for picking   Read More

Analyst Alp Erdogan says that in 2019, capital that bloated the 2018 prices of cryptocurrencies, cannabis stocks and blockchain technology generally will shift toward value stocks with better defensive characteristics.   Read More

‘Where there’s smoke, there’s . . . opportunity’ concludes The MoneyLetter after surveying a number of security analysts’ reports on medical cannabis producers in Canada. Companies already established in the   Read More

Cardinal Health’s problems with Cordis, plus the negative impact of generic drug pricing on company profits, has given us pause on this healthcare stock. We recommend that purchases be deferred   Read More

Seniors housing and business software technology may make for an odd couple on anybody’s ‘best of anything’ list. But chartered financial analyst Christine Poole sees money to be made from   Read More

Beacon Securities head of research, Toronto-based Doug Cooper, analyzed New Look Vision Group’s latest acquisition and concluded that the transaction not only grows New Look’s store count by about 66   Read More

Portfolio manager Lorne Zeiler picks a US-based global healthcare stock and a Canadian preferred share exchange traded fund as his current two ‘best buys’ for investors seeking high dividend income   Read More

Medtronic PLC is a medical technology stock. It earned record profits in the year ended April 28. It’s expected to earn record profits in fiscal 2018 (which began April 29)   Read More

An infrastructure stock and a healthcare stock sound like an odd couple for investment counsellor Robert Sneddon’s two ‘best buy’ stock selections. But Mr. Sneddon forecasts a strong bull run   Read More

Canopy Growth is a diversified cannabis company engaged in growing and distributing medical marijuana products to patients across Canada. Mettrum Health Corp. is also a producer of medical cannabis and   Read More

American Depositary Receipts, or ADRs, give you benefits. One is global portfolio diversification. It’s tempting to call ADRs American ‘Diversification’ Receipts. They give you industries that Canada lacks or has   Read More

Sentry Investments analyst Andy Nasr identifies two U.S. stocks that will continue to prosper regardless of the U.S. election results. One is a pharmacy operator popular with drugstore-cowboy seniors. The   Read More

CRH Medical offers services and related medical instruments and equipment to physicians focused on providing screening and treatment of gastrointestinal ailments. Investment dealer Acumen Capital says the CRH Q2 results   Read More

If death and taxes are certain, then surely their close siblings, aging and debt, are never too far away. Portfolio manager Robert McWhirter has found a healthcare stock and a   Read More

A frequent contributor to Investor’s Digest of Canada, Elvis Picardo is on a roll. His picks for the popular ‘Best Buys’ from Leading Analysts column in December, 2015, and March,   Read More

Reflecting on the rise and fall of one-time TSX favourite healthcare stock Valeant Pharmaceuticals, performance improvement specialist Sam Watts warns readers that a company’s continuous acquisitions can cause management to   Read More

Analysts follow as many as 20 stocks, most of which are rated “buys.” Of those buys, an analyst has one or two special favorites seen as most suitable for new   Read More

Headquartered in Vancouver, CRH Medical sells products and services to doctors who screen and treat gastrointestinal ailments. Until recently, CRH was a medical device company, boasting a single product. But   Read More

The TSX Venture Exchange is not your father’s stock exchange. Elvis Picardo, vice president of research and portfolio manager at Global Securities Corp. in Vancouver, notes that instead of being   Read More

Based in Oakville, Ont., Canadian healthcare stock Concordia Healthcare Corp. buys and manages legacy pharma products. It also buys and develops orphan drugs. Thanks to a recent acquisition, this healthcare   Read More

John Stephenson, portfolio manager and president of Toronto-based Stephenson & Company Capital Management Inc., says the recent dramatic decline in the greenback is unlikely to be sustained for an extended   Read More

Former Investor’s Digest of Canada editor Carlyle Dunbar argues that deflation is on its way. But when? In the meantime large-cap healthcare and information technology stocks are now starring on   Read More

In mid-2015 Baxter will split into two companies. One will focus on medical products for healthcare solutions; the other on developing and marketing biopharmaceuticals.
On March 9, there was an anniversary   Read More